Skip to main content
Home
  • About Us
    • About Us
    • Mission & Values
    • Leadership
    • News
    • Careers
    • Partnerships
    • Support
    • Achievements
  • For Researchers
    • Clinical Trials
      • Allergy & Asthma
      • Autoimmune Disease
      • Transplantation
      • Type 1 Diabetes
    • Core Facilities
    • Lab Protocols
      • ITN Protocols
      • T1D Preclinical Consortium
    • Policies
      • Publications Policy
    • Proposals
      • Submit Proposal
      • Current RFPs
      • Past RFPs
    • Publications
    • TrialShare
    • Strategic Plans
      • Allergy
      • Autoimmune Disease
        • Type 1 Diabetes
      • Transplantation
  • For Patients
    • Allergy & Asthma
    • Autoimmune Disease
    • Transplantation
      • Kidney
      • Liver
    • Type 1 Diabetes
    • Clinical Trial Info
  • TrialShare
  • Contact
    • Contact Us
      • BRI - Seattle Office
      • UCSF - San Francisco Office
    • Media Inquiries
Home

Secondary links

  • Home
  • TrialShare
  • Member Portal
  • About Us
    • About Us
    • Mission & Values
    • Leadership
    • News
    • Careers
    • Partnerships
    • Support
    • Achievements
  • For Researchers
    • Clinical Trials
    • Core Facilities
    • Lab Protocols
    • Policies
    • Proposals
    • Publications
    • TrialShare
    • Strategic Plans
  • For Patients
    • Allergy & Asthma
    • Autoimmune Disease
    • Transplantation
    • Type 1 Diabetes
    • Clinical Trial Info
  • TrialShare
  • Contact
    • Contact Us
    • Media Inquiries

Primary links

  • About Us
  • Mission & Values
  • Leadership
  • News
  • Careers
  • Partnerships
  • Support
  • Achievements

Welcome to our new look...

November 20, 2008 --

As you may have noticed, the Immune Tolerance Network (ITN) website has undergone some pretty major changes. We hope you enjoy the new look and will find the new site easier to navigate and as informative as our previous versions.

Our website has gone through several iterations since the ITN was founded in 1999. Prior to this redesign, the last revision took place in May 2002, when the ITN was still relatively young and was conducting only a handful of clinical trials. Today the ITN has a growing portfolio of over 20 clinical trials, a full-time staff of over 80, over a dozen validated core facilities and research collaborations with numerous industry, academic and government partners. The new design reflects the dynamic nature of the ITN, highlighting some of our investigators and others who have come together under the banner of the ITN.

Choose your flavor

ITN splash pageWhen you enter from www.immunetolerance.org for the first time, you will be given the choice between the "Research Professionals" pages or the "General Public" pages. Choose one, and the next time you visit, you'll automatically be taken to those pages (however, if you clear the cookies from your browser, you may be asked to choose again on your next visit). If you change your mind mid-visit, you can always switch using the links at the bottom of each page.

News where you want to read it

rss feedOver the coming months, we'll be updating the site regularly with news about new and existing ITN trials, research developments and feature stories about ITN people and research. You now have the option of subscribing to ITN news using RSS. Click on the RSS icon (like the one at right) in your browser, or copy the following URL into your RSS reader to subscribe - http://www.immunetolerance.org/professionals/feed.

We hope you like our new look! As always, we appreciate your feedback. Please send all comments to webmaster@immunetolerance.org.

The Immune Tolerance Network and is sponsored by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

National Institute of Allergy and Infectious Diseases

Footer

  • Home
  • Sponsors
  • Careers
  • Contact
  • Search

© 2021 Immune Tolerance Network

  • Privacy
  • Terms of Use
  • Accessibility